Intervention Protocol

Calcium channel blockers for people with chronic kidney disease requiring dialysis

  1. George A Mugendi1,*,
  2. Giovanni FM Strippoli2,3,4,5,6,
  3. Florence M Mutua7,
  4. Tonya M Esterhuizen8

Editorial Group: Cochrane Renal Group

Published Online: 12 APR 2014

DOI: 10.1002/14651858.CD011064


How to Cite

Mugendi GA, Strippoli GFM, Mutua FM, Esterhuizen TM. Calcium channel blockers for people with chronic kidney disease requiring dialysis (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 4. Art. No.: CD011064. DOI: 10.1002/14651858.CD011064.

Author Information

  1. 1

    University of Nairobi, Pharmaceutics and Pharmacy Practice, School of Pharmacy, Nairobi, Nairobi, Kenya

  2. 2

    The Children's Hospital at Westmead, Cochrane Renal Group, Centre for Kidney Research, Westmead, NSW, Australia

  3. 3

    University of Bari, Department of Emergency and Organ Transplantation, Bari, Italy

  4. 4

    Mario Negri Sud Consortium, Department of Clinical Pharmacology and Epidemiology, Santa Maria Imbaro, Italy

  5. 5

    The University of Sydney, Sydney School of Public Health, Sydney, Australia

  6. 6

    Diaverum, Medical-Scientific Office, Lund, Sweden

  7. 7

    University of Nairobi, Department of Medical Microbiology, College of Health Sciences, Nairobi, Kenya

  8. 8

    Stellenbosch University, Centre for Evidence-based Health Care, Faculty of Medicine and Health Sciences, Cape Town, South Africa

*George A Mugendi, Pharmaceutics and Pharmacy Practice, School of Pharmacy, University of Nairobi, PO Box 19676, Nairobi, Nairobi, 00202, Kenya. gendike@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 12 APR 2014

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

This review aims to look at the benefits and harms of CCB for people with CKD requiring dialysis.